Dr. Kristen Fortney is the Chief Executive Officer of BioAge Labs, a venture-backed computational biology startup in Berkeley, California. BioAge Labs was founded in 2015 and couples genomic data with machine learning to measure human aging and accelerate drug discovery.

Dr. Fortney received her PhD in Medical Biophysics from the University of Toronto in 2012, and completed her postdoctoral training at Stanford University, where she was a postdoctoral fellow of the Ellison Medical Foundation / American Federation for Aging Research. She is an expert at developing novel bioinformatics approaches that harness large amounts of data to shed light on mechanisms of aging and age-related disease. Her research has focused on computational drug discovery, biomarkers of aging, and the genetics of exceptional human longevity.